{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:03:15Z","timestamp":1791849795404,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,7,23]],"date-time":"2006-07-23T00:00:00Z","timestamp":1153612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,7,23]],"date-time":"2006-07-23T00:00:00Z","timestamp":1153612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1038\/nm1446","type":"journal-article","created":{"date-parts":[[2006,7,23]],"date-time":"2006-07-23T13:35:22Z","timestamp":1153661722000},"page":"908-916","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":977,"title":["Cardiotoxicity of the cancer therapeutic agent imatinib mesylate"],"prefix":"10.1038","volume":"12","author":[{"given":"Risto","family":"Kerkel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanda","family":"Grazette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Yacobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Beahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Shevtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Pesant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred J","family":"Clubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Van Etten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Alroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Force","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,23]]},"reference":[{"issue":"Suppl. 1","key":"BFnm1446_CR1","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.leukres.2003.10.005","volume":"28","author":"RA Van Etten","year":"2004","unstructured":"Van Etten, R.A. Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era. Leuk. Res. 28 (Suppl. 1), S21\u2013S28 (2004).","journal-title":"Leuk. Res."},{"key":"BFnm1446_CR2","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger, M., Buchdunger, E. & Druker, B.J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640\u20132653 (2005).","journal-title":"Blood"},{"key":"BFnm1446_CR3","first-page":"935","volume":"8","author":"MH Cohen","year":"2002","unstructured":"Cohen, M.H. et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin. Cancer Res. 8, 935\u2013942 (2002).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1446_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/01.CIR.0000013839.41224.1C","volume":"105","author":"DB Sawyer","year":"2002","unstructured":"Sawyer, D.B., Zuppinger, C., Miller, T.A., Eppenberger, H.M. & Suter, T.M. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1\u03b2 and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity. Circulation 105, 1551\u20131554 (2002).","journal-title":"Circulation"},{"key":"BFnm1446_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2004.08.066","volume":"44","author":"LP Grazette","year":"2004","unstructured":"Grazette, L.P. et al. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J. Am. Coll. Cardiol. 44, 2231\u20132238 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnm1446_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond, E.H. et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N. Engl. J. Med. 353, 1673\u20131684 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1446_CR7","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"MJ Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart, M.J. et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med. 353, 1659\u20131672 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1446_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.94.4.1437","volume":"94","author":"ZM Yuan","year":"1997","unstructured":"Yuan, Z.M. et al. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94, 1437\u20131440 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1446_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/ncb1228","volume":"7","author":"K Yoshida","year":"2005","unstructured":"Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D. & Miki, Y. JNK phosphorylation of 14\u20133-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol. 7, 278\u2013285 (2005).","journal-title":"Nat. Cell Biol."},{"key":"BFnm1446_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0962-8924(99)01549-4","volume":"9","author":"RA Van Etten","year":"1999","unstructured":"Van Etten, R.A. Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol. 9, 179\u2013186 (1999).","journal-title":"Trends Cell Biol."},{"key":"BFnm1446_CR11","doi-asserted-by":"publisher","first-page":"17237","DOI":"10.1074\/jbc.C000099200","volume":"275","author":"X Sun","year":"2000","unstructured":"Sun, X. et al. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J. Biol. Chem. 275, 17237\u201317240 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm1446_CR12","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1101\/gad.1223504","volume":"18","author":"B Li","year":"2004","unstructured":"Li, B. et al. Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C\u03b4. Genes Dev. 18, 1824\u20131837 (2004).","journal-title":"Genes Dev."},{"key":"BFnm1446_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ng1396","volume":"36","author":"X Deng","year":"2004","unstructured":"Deng, X. et al. Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. Nat. Genet. 36, 906\u2013912 (2004).","journal-title":"Nat. Genet."},{"key":"BFnm1446_CR14","doi-asserted-by":"publisher","first-page":"29667","DOI":"10.1074\/jbc.M301292200","volume":"278","author":"C Cao","year":"2003","unstructured":"Cao, C., Leng, Y. & Kufe, D. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J. Biol. Chem. 278, 29667\u201329675 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1446_CR15","doi-asserted-by":"publisher","first-page":"39609","DOI":"10.1074\/jbc.M305770200","volume":"278","author":"C Cao","year":"2003","unstructured":"Cao, C., Leng, Y., Huang, W., Liu, X. & Kufe, D. Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases. J. Biol. Chem. 278, 39609\u201339614 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1446_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0002-8703(00)90084-X","volume":"139","author":"RS Vasan","year":"2000","unstructured":"Vasan, R.S., Levy, D., Larson, M.G. & Benjamin, E.J. Interpretation of echocardiographic measurements: a call for standardization. Am. Heart J. 139, 412\u2013422 (2000).","journal-title":"Am. Heart J."},{"key":"BFnm1446_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0301-0082(95)00015-N","volume":"46","author":"MA Khan","year":"1995","unstructured":"Khan, M.A. Effects of myotoxins on skeletal muscle fibers. Prog. Neurobiol. 46, 541\u2013560 (1995).","journal-title":"Prog. Neurobiol."},{"key":"BFnm1446_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1172\/JCI200419603","volume":"114","author":"CE Daniels","year":"2004","unstructured":"Daniels, C.E. et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-\u03b2 and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 114, 1308\u20131316 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnm1446_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly, R.T. et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J. Clin. Invest. 115, 2811\u20132821 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm1446_CR20","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1182\/blood.V98.9.2808","volume":"98","author":"NC Wolff","year":"2001","unstructured":"Wolff, N.C. & Ilaria, R.L., Jr. Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. Blood 98, 2808\u20132816 (2001).","journal-title":"Blood"},{"key":"BFnm1446_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jnci\/91.2.163","volume":"91","author":"P le Coutre","year":"1999","unstructured":"le Coutre, P. et al. In vivo eradication of human BCR\/ABL-positive leukemia cells with an ABL kinase inhibitor. J. Natl. Cancer Inst. 91, 163\u2013168 (1999).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm1446_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng1343","volume":"36","author":"Y Hu","year":"2004","unstructured":"Hu, Y. et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat. Genet. 36, 453\u2013461 (2004).","journal-title":"Nat. Genet."},{"key":"BFnm1446_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tcm.2005.05.001","volume":"15","author":"CJ McLeod","year":"2005","unstructured":"McLeod, C.J., Pagel, I. & Sack, M.N. The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia\u2013a putative target for therapeutic intervention. Trends Cardiovasc. Med. 15, 118\u2013123 (2005).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnm1446_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines, C.P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658\u2013662 (2005).","journal-title":"Nature"},{"key":"BFnm1446_CR25","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1073\/pnas.0503324102","volume":"102","author":"A Sanbe","year":"2005","unstructured":"Sanbe, A. et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc. Natl. Acad. Sci. USA 102, 13592\u201313597 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1446_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0896-6273(03)00601-9","volume":"40","author":"J Yuan","year":"2003","unstructured":"Yuan, J., Lipinski, M. & Degterev, A. Diversity in the mechanisms of neuronal cell death. Neuron 40, 401\u2013413 (2003).","journal-title":"Neuron"},{"key":"BFnm1446_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/0896-6273(95)90186-8","volume":"15","author":"M Ankarcrona","year":"1995","unstructured":"Ankarcrona, M. et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961\u2013973 (1995).","journal-title":"Neuron"},{"key":"BFnm1446_CR28","doi-asserted-by":"publisher","first-page":"47985","DOI":"10.1074\/jbc.M405071200","volume":"279","author":"CL Murriel","year":"2004","unstructured":"Murriel, C.L., Churchill, E., Inagaki, K., Szweda, L.I. & Mochly-Rosen, D. Protein kinase C\u03b4 activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J. Biol. Chem. 279, 47985\u201347991 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1446_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/BJ20040704","volume":"384","author":"SF Steinberg","year":"2004","unstructured":"Steinberg, S.F. Distinctive activation mechanisms and functions for protein kinase C\u03b4. Biochem. J. 384, 449\u2013459 (2004).","journal-title":"Biochem. J."},{"key":"BFnm1446_CR30","doi-asserted-by":"publisher","first-page":"25935","DOI":"10.1074\/jbc.R400008200","volume":"279","author":"K Zhang","year":"2004","unstructured":"Zhang, K. & Kaufman, R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J. Biol. Chem. 279, 25935\u201325938 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1446_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce, M. et al. A selective inhibitor of eIF2\u03b1 dephosphorylation protects cells from ER stress. Science 307, 935\u2013939 (2005).","journal-title":"Science"},{"key":"BFnm1446_CR32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI0216784","volume":"110","author":"D Ron","year":"2002","unstructured":"Ron, D. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. 110, 1383\u20131388 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnm1446_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrm1618","volume":"6","author":"M Holcik","year":"2005","unstructured":"Holcik, M. & Sonenberg, N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 6, 318\u2013327 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnm1446_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881\u2013891 (2001).","journal-title":"Cell"},{"key":"BFnm1446_CR35","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1128\/MCB.23.21.7448-7459.2003","volume":"23","author":"AH Lee","year":"2003","unstructured":"Lee, A.H., Iwakoshi, N.N. & Glimcher, L.H. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23, 7448\u20137459 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1446_CR36","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.287.5453.664","volume":"287","author":"F Urano","year":"2000","unstructured":"Urano, F. et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664\u2013666 (2000).","journal-title":"Science"},{"key":"BFnm1446_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1101\/gad.992302","volume":"16","author":"H Nishitoh","year":"2002","unstructured":"Nishitoh, H. et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16, 1345\u20131355 (2002).","journal-title":"Genes Dev."},{"key":"BFnm1446_CR38","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nm911","volume":"9","author":"T Borsello","year":"2003","unstructured":"Borsello, T. et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180\u20131186 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1446_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2004.11.004","volume":"38","author":"CP Baines","year":"2005","unstructured":"Baines, C.P. & Molkentin, J.D. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J. Mol. Cell. Cardiol. 38, 47\u201362 (2005).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnm1446_CR40","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre, M.E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876\u2013880 (2001).","journal-title":"Science"},{"key":"BFnm1446_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0145-2126(03)00218-2","volume":"28","author":"L Pattacini","year":"2004","unstructured":"Pattacini, L. et al. Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. Leuk. Res. 28, 191\u2013202 (2004).","journal-title":"Leuk. Res."},{"key":"BFnm1446_CR42","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1128\/MCB.21.18.6233-6242.2001","volume":"21","author":"Y Ito","year":"2001","unstructured":"Ito, Y. et al. Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis. Mol. Cell. Biol. 21, 6233\u20136242 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1446_CR43","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/sj.cdd.4401378","volume":"11","author":"RV Rao","year":"2004","unstructured":"Rao, R.V., Ellerby, H.M. & Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 11, 372\u2013380 (2004).","journal-title":"Cell Death Differ."},{"key":"BFnm1446_CR44","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1126\/science.288.5467.870","volume":"288","author":"C Tournier","year":"2000","unstructured":"Tournier, C. et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870\u2013874 (2000).","journal-title":"Science"},{"key":"BFnm1446_CR45","doi-asserted-by":"publisher","first-page":"10244","DOI":"10.1074\/jbc.M112355200","volume":"277","author":"H Aoki","year":"2002","unstructured":"Aoki, H. et al. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiomyocytes. J. Biol. Chem. 277, 10244\u201310250 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1446_CR46","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/sj.emboj.7600194","volume":"23","author":"F Tsuruta","year":"2004","unstructured":"Tsuruta, F. et al. JNK promotes Bax translocation to mitochondria through phosphorylation of 14\u20133-3 proteins. EMBO J. 23, 1889\u20131899 (2004).","journal-title":"EMBO J."},{"key":"BFnm1446_CR47","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1182\/blood-2003-05-1605","volume":"103","author":"M Okada","year":"2004","unstructured":"Okada, M. et al. A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 103, 2299\u20132307 (2004).","journal-title":"Blood"},{"key":"BFnm1446_CR48","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller, N.B. et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 2, 358\u2013367 (1989).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"BFnm1446_CR49","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm891","volume":"9","author":"S Haq","year":"2003","unstructured":"Haq, S. et al. Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat. Med. 9, 944\u2013951 (2003).","journal-title":"Nat. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1446","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:39Z","timestamp":1650326439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,23]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8,1]]}},"alternative-id":["BFnm1446"],"URL":"https:\/\/doi.org\/10.1038\/nm1446","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1033567.489987","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1033567.388749","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1033567.550029","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,23]]},"assertion":[{"value":"4 May 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}